Video

Is It Time To Leave Your CDMO?

Source: Outsourced Pharma

This segment of the Outsourced Pharma Live event, “Your CDMO Quality Oversight Is Not Working,” examines how sponsors can determine whether a troubled CDMO relationship can be repaired. Andrea and Greg discuss what meaningful ownership of a problem looks like, why repeated resistance to feedback raises concerns about quality culture, and how limited funding and lengthy transfer timelines complicate the decision to leave. The conversation emphasizes clear commitments, evidence of improvement, and a shared responsibility for keeping programs moving toward patients. Featuring Andrea Goddard, CTO, CatalYm GmbH, and Greg Whitehead, EVP/CTO, Editas Medicine.

Access The Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma